BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15225704)

  • 1. Synthesis and biological evaluation of flavonoids as vasorelaxant agents.
    Chen Z; Hu Y; Wu H; Jiang H
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3949-52. PubMed ID: 15225704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of SVM-based classification model, synthesis and evaluation of prenylated flavonoids as vasorelaxant agents.
    Dong X; Liu Y; Yan J; Jiang C; Chen J; Liu T; Hu Y
    Bioorg Med Chem; 2008 Sep; 16(17):8151-60. PubMed ID: 18678502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synthesis and vasorelaxation action of flavonoids].
    Chen ZW; Hu YZ; Wu HH; Jiang HD
    Yao Xue Xue Bao; 2005 Nov; 40(11):1001-7. PubMed ID: 16499084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological evaluation and quantitative structure-activities relationship of flavonoids as vasorelaxant agents.
    Dong X; Liu T; Yan J; Wu P; Chen J; Hu Y
    Bioorg Med Chem; 2009 Jan; 17(2):716-26. PubMed ID: 19070497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of n-butylphthalide derivatives.
    Wang W; Cha XX; Reiner J; Gao Y; Qiao HL; Shen JX; Chang JB
    Eur J Med Chem; 2010 May; 45(5):1941-6. PubMed ID: 20133025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biological evaluation of prenylflavonoids as vasorelaxant and neuroprotective agents.
    Dong X; Qi L; Jiang C; Chen J; Wei E; Hu Y
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3196-8. PubMed ID: 19442520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel hybrid chalcone derivatives as vasorelaxant agents.
    Dong X; Du L; Pan Z; Liu T; Yang B; Hu Y
    Eur J Med Chem; 2010 Sep; 45(9):3986-92. PubMed ID: 20566231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation and structure-activity relationships of new phthalazinedione derivatives with vasorelaxant activity.
    Munín J; Quezada E; Cuiñas A; Campos-Toimil M; Uriarte E; Santana L; Viña D
    Eur J Med Chem; 2014 Jul; 82():407-17. PubMed ID: 24929291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of prenylated chalcones as vasorelaxant agents.
    Dong X; Chen J; Jiang C; Liu T; Hu Y
    Arch Pharm (Weinheim); 2009 Jul; 342(7):428-32. PubMed ID: 19544479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavonoids as vasorelaxant agents: synthesis, biological evaluation and quantitative structure activities relationship (QSAR) studies.
    Dong X; Wang Y; Liu T; Wu P; Gao J; Xu J; Yang B; Hu Y
    Molecules; 2011 Sep; 16(10):8257-72. PubMed ID: 21959298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasorelaxant effect of flavonoids through calmodulin inhibition: Ex vivo, in vitro, and in silico approaches.
    Torres-Piedra M; Figueroa M; Hernández-Abreu O; Ibarra-Barajas M; Navarrete-Vázquez G; Estrada-Soto S
    Bioorg Med Chem; 2011 Jan; 19(1):542-6. PubMed ID: 21129983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of 2-substituted-6-phenyl-4,5-dihydropyridazin-3(2H)-ones as potent inodilators.
    Kumar D; Carron R; La Calle CD; Jindal DP; Bansal R
    Acta Pharm; 2008 Dec; 58(4):393-405. PubMed ID: 19103574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies towards the identification of putative bioactive conformation of potent vasodilator arylidene N-acylhydrazone derivatives.
    Kümmerle AE; Raimundo JM; Leal CM; da Silva GS; Balliano TL; Pereira MA; de Simone CA; Sudo RT; Zapata-Sudo G; Fraga CA; Barreiro EJ
    Eur J Med Chem; 2009 Oct; 44(10):4004-9. PubMed ID: 19500884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, vasorelaxant activity and 2D-QSAR study of some novel pyridazine derivatives.
    George RF; Saleh DO
    Eur J Med Chem; 2016 Jan; 108():663-673. PubMed ID: 26735908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasorelaxant activity of 7-β-O-glycosides biosynthesized from flavonoids.
    Penso J; Cordeiro KC; da Cunha CR; da Silva Castro PF; Martins DR; Lião LM; Rocha ML; de Oliveira V
    Eur J Pharmacol; 2014 Jun; 733():75-80. PubMed ID: 24704375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of flavonoids for vascular relaxation in porcine coronary artery.
    Xu YC; Leung SW; Yeung DK; Hu LH; Chen GH; Che CM; Man RY
    Phytochemistry; 2007 Apr; 68(8):1179-88. PubMed ID: 17395220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasorelaxant activity of diterpenes from Croton zambesicus and synthetic trachylobanes and their structure-activity relationships.
    Baccelli C; Navarro I; Block S; Abad A; Morel N; Quetin-Leclercq J
    J Nat Prod; 2007 Jun; 70(6):910-7. PubMed ID: 17547457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasorelaxant effect of the rootbark extract of Paeonia moutan on isolated rat thoracic aorta.
    Yoo MY; Lee BH; Choi YH; Lee JW; Seo JH; Oh KS; Koo HN; Seo HW; Yon GH; Kwon DY; Kim YS; Ryu SY
    Planta Med; 2006 Nov; 72(14):1338-41. PubMed ID: 17051461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, ex vivo and in silico studies of 3-cyano-2-pyridone derivatives with vasorelaxant activity.
    Hernández F; Sánchez A; Rendón-Vallejo P; Millán-Pacheco C; Alcaraz Y; Delgado F; Vázquez MA; Estrada-Soto S
    Eur J Med Chem; 2013; 70():669-76. PubMed ID: 24212125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design, synthesis and QSAR study of vasorelaxant active 3-pyridinecarbonitriles incorporating 1H-benzimidazol-2-yl function.
    Nofal ZM; Srour AM; El-Eraky WI; Saleh DO; Girgis AS
    Eur J Med Chem; 2013 May; 63():14-21. PubMed ID: 23454530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.